Spirulina and Tryptophan-Kynurenine Balance

Tryptophan: The Bifurcating Amino Acid

Tryptophan is an essential amino acid (~4 mg/kg/day requirement) with two principal metabolic fates. The minor branch: TPH1/TPH2 hydroxylates tryptophan to 5-hydroxytryptophan, decarboxylated to serotonin (peripheral and CNS) and subsequently melatonin in the pineal. The major branch (~95% of systemic tryptophan): IDO/TDO oxidizes tryptophan to N-formylkynurenine, the first step of the kynurenine pathway.

IDO Activation by Inflammation

Indoleamine 2,3-dioxygenase 1 (IDO1) is induced by IFN-γ, LPS, and TNF-α in macrophages, dendritic cells, and endothelial cells. Tryptophan 2,3-dioxygenase (TDO) operates in hepatocytes constitutively. In chronic inflammation, IDO1 induction increases kynurenine flux 2–5 fold while depleting tryptophan available for serotonin synthesis. Spirulina reduces IDO1 expression by 25–40% via IFN-γ pathway suppression and direct STAT1 attenuation.

Neurotoxic vs Neuroprotective Branches

Kynurenine metabolism bifurcates again: KMO (kynurenine 3-monooxygenase) produces 3-hydroxykynurenine and ultimately quinolinic acid (QUIN), an NMDA receptor agonist and excitotoxin associated with depression, neurodegeneration, and HIV-associated cognitive impairment. KAT enzymes produce kynurenic acid (KYNA), an NMDA antagonist with neuroprotective and immunomodulatory effects. Inflammation favors the KMO/QUIN branch; phycocyanin shifts the balance toward the KAT/KYNA branch.

AhR Ligands from Tryptophan

Kynurenine itself is an aryl hydrocarbon receptor (AhR) ligand, as are tryptophan-derived microbial indoles (indole-3-aldehyde, indole-3-acetate). Physiologic AhR activation supports Treg differentiation, intestinal barrier function (via IL-22 induction in ILC3 cells), and CYP1A1-mediated xenobiotic detoxification. Spirulina enriches indole-producing gut bacteria (Lactobacillus), increasing beneficial AhR ligand production.

Quinolinic Acid and Depression

Elevated QUIN/KYNA ratio is mechanistically linked to major depressive disorder. QUIN-mediated NMDA receptor overactivation drives glutamatergic excitotoxicity and neuroinflammation. Inflammation-induced depression (sickness behavior, post-COVID depression, IFN-α therapy) is mediated through this pathway. Spirulina's IDO suppression and IFN-γ/TNF-α reduction normalize QUIN/KYNA ratio by 20–35%.

Conclusion

Spirulina restores tryptophan-kynurenine homeostasis through IDO1 suppression (25–40% reduction), KAT branch favoring (20–35% QUIN/KYNA improvement), beneficial AhR ligand provision via microbiota modulation, and preserved serotonin precursor pool. Clinical correlates: improved mood metrics in chronic inflammation, antidepressant-like effects in animal models of inflammation-induced depression, and reduced neurodegeneration biomarkers. The tryptophan-kynurenine axis bridges immune function and neuropsychiatric outcomes — an area where spirulina's anti-inflammatory mechanisms translate directly into mental health effects.